These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1438 related articles for article (PubMed ID: 25232278)

  • 1. Antibiotics and bacterial resistance in the 21st century.
    Fair RJ; Tor Y
    Perspect Medicin Chem; 2014; 6():25-64. PubMed ID: 25232278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. History of Antibiotics Research.
    Mohr KI
    Curr Top Microbiol Immunol; 2016; 398():237-272. PubMed ID: 27738915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic-resistant bacteria: a challenge for the food industry.
    Capita R; Alonso-Calleja C
    Crit Rev Food Sci Nutr; 2013; 53(1):11-48. PubMed ID: 23035919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical Synergy between Ionophore PBT2 and Zinc Reverses Antibiotic Resistance.
    Bohlmann L; De Oliveira DMP; El-Deeb IM; Brazel EB; Harbison-Price N; Ong CY; Rivera-Hernandez T; Ferguson SA; Cork AJ; Phan MD; Soderholm AT; Davies MR; Nimmo GR; Dougan G; Schembri MA; Cook GM; McEwan AG; von Itzstein M; McDevitt CA; Walker MJ
    mBio; 2018 Dec; 9(6):. PubMed ID: 30538186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to antibiotics: are we in the post-antibiotic era?
    Alanis AJ
    Arch Med Res; 2005; 36(6):697-705. PubMed ID: 16216651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidrug-resistant gram-negative organisms: a review of recently approved antibiotics and novel pipeline agents.
    Provenzani A; Hospodar AR; Meyer AL; Leonardi Vinci D; Hwang EY; Butrus CM; Polidori P
    Int J Clin Pharm; 2020 Aug; 42(4):1016-1025. PubMed ID: 32638294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next-generation strategy for treating drug resistant bacteria: Antibiotic hybrids.
    Gupta V; Datta P
    Indian J Med Res; 2019 Feb; 149(2):97-106. PubMed ID: 31219074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisphosphocins: novel antimicrobials for enhanced killing of drug-resistant and biofilm-forming bacteria.
    Wong JP; DiTullio P; Parkinson S
    Future Microbiol; 2015; 10(11):1751-8. PubMed ID: 26597426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic efflux pumps in Gram-negative bacteria: the inhibitor response strategy.
    Mahamoud A; Chevalier J; Alibert-Franco S; Kern WV; Pagès JM
    J Antimicrob Chemother; 2007 Jun; 59(6):1223-9. PubMed ID: 17229832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations among Antibiotic and Phage Resistance Phenotypes in Natural and Clinical
    Allen RC; Pfrunder-Cardozo KR; Meinel D; Egli A; Hall AR
    mBio; 2017 Oct; 8(5):. PubMed ID: 29089428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging antibiotic resistance: carbapenemase-producing enterobacteria. Bad new bugs, still no new drugs.
    Spera AM; Esposito S; Pagliano P
    Infez Med; 2019 Dec; 27(4):357-364. PubMed ID: 31846984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance of Gram-Negative Bacteria to Current Antibacterial Agents and Approaches to Resolve It.
    Breijyeh Z; Jubeh B; Karaman R
    Molecules; 2020 Mar; 25(6):. PubMed ID: 32187986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phage-Antibiotic Synergy Is Driven by a Unique Combination of Antibacterial Mechanism of Action and Stoichiometry.
    Gu Liu C; Green SI; Min L; Clark JR; Salazar KC; Terwilliger AL; Kaplan HB; Trautner BW; Ramig RF; Maresso AW
    mBio; 2020 Aug; 11(4):. PubMed ID: 32753497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibacterial Discovery: 21st Century Challenges.
    Hoffman PS
    Antibiotics (Basel); 2020 Apr; 9(5):. PubMed ID: 32353943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. XF drugs: A new family of antibacterials.
    Pereira Gonzales F; Maisch T
    Drug News Perspect; 2010 Apr; 23(3):167-74. PubMed ID: 20440418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Classes of Antibacterial Drugs in Clinical Development, a Hope in a Post-antibiotic Era.
    Campanini-Salinas J; Andrades-Lagos J; Mella-Raipan J; Vasquez-Velasquez D
    Curr Top Med Chem; 2018; 18(14):1188-1202. PubMed ID: 30117393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New antibiotics for bad bugs: where are we?
    Bassetti M; Merelli M; Temperoni C; Astilean A
    Ann Clin Microbiol Antimicrob; 2013 Aug; 12():22. PubMed ID: 23984642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Old and new targets of antibacterial therapy.
    Dbaibo GS
    J Med Liban; 2000; 48(4):177-81. PubMed ID: 11214186
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 72.